MARC보기
LDR06029cmm u2200781 i 4500
001000000312022
003OCoLC
00520230525151329
006m d
007cr un|||||||||
008170802s2017 dcua ob 000 0 eng
0167 ▼a 101710588 ▼2 DNLM
019 ▼a 992788801 ▼a 992957941 ▼a 993069223 ▼a 1000430219
020 ▼a 9780309451338 ▼q (electronic bk.)
020 ▼a 0309451337 ▼q (electronic bk.)
020 ▼z 9780309451321
020 ▼z 0309451329
035 ▼a 1546474 ▼b (N$T)
035 ▼a (OCoLC)972079088 ▼z (OCoLC)992788801 ▼z (OCoLC)992957941 ▼z (OCoLC)993069223 ▼z (OCoLC)1000430219
040 ▼a NLM ▼b eng ▼e rda ▼c NLM ▼d YDX ▼d SCB ▼d MMU ▼d OCLCF ▼d LVT ▼d IUL ▼d EBLCP ▼d MERUC ▼d N$T ▼d 248032
042 ▼a pcc
043 ▼a n-us---
049 ▼a MAIN
050 4 ▼a RC280.L8
06000 ▼a WF 658
072 7 ▼a HEA ▼x 039000 ▼2 bisacsh
072 7 ▼a MED ▼x 014000 ▼2 bisacsh
072 7 ▼a MED ▼x 022000 ▼2 bisacsh
072 7 ▼a MED ▼x 112000 ▼2 bisacsh
072 7 ▼a MED ▼x 045000 ▼2 bisacsh
08204 ▼a 616.99424 ▼2 23
1001 ▼a Balogh, Erin, ▼e rapporteur.
24510 ▼a Implementation of lung cancer screening : ▼b proceedings of a workshop / ▼c Erin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.
260 ▼a Washington, DC : ▼b the National Academies Press, ▼c [2017]
300 ▼a 1 online resource (1 PDF file (xxii, 105 pages)) : ▼b illustrations.
336 ▼a text ▼b txt ▼2 rdacontent
337 ▼a computer ▼b c ▼2 rdamedia
338 ▼a online resource ▼b cr ▼2 rdacarrier
504 ▼a Includes bibliographical references.
5050 ▼a Pages:1 to 25; Pages:26 to 50; Pages:51 to 75; Pages:76 to 100; Pages:101 to 125; Pages:126 to 129
5203 ▼a The public health burden from lung cancer is substantial: it is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths in the United States. Given the individual and population health burden of lung cancer, especially when it is diagnosed at later stages, there has been a push to develop and implement screening strategies for early detection. However, many factors need to be considered for broad implementation of lung cancer screening in clinical practice. Effective implementation will entail understanding the balance of potential benefits and harms of lung cancer screening, defining and reaching eligible populations, addressing health disparities, and many more considerations. In recognition of the substantial challenges to developing effective lung cancer screening programs in clinical practice, the National Academies of Sciences, Engineering, and Medicine held a workshop in June 2016. At the workshop, experts described the current evidence base for lung cancer screening, the current challenges of implementation, and opportunities to overcome them. Workshop participants also explored capacity and access issues; best practices for screening programs; assessment of patient outcomes, quality, and value in lung cancer screening; and research needs that could improve implementation efforts. This publication summarizes the presentations and discussions from the workshop.
536 ▼a This project was supported by Contract No. 200-2011-38807 (Task Order No. 0051) and Contract No. HHSN263201200074I (Task Order No. HHSN26300052) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research, American Cancer Society, American College of Radiology, American Society for Radiation Oncology, American Society of Clinical Oncology, American Society of Hematology, Association of American Cancer Institutes, AstraZeneca, Bristol-Myers Squibb, Cancer Support Community, CEO Roundtable on Cancer, Helsinn Healthcare SA, LIVESTRONG Foundation, National Comprehensive Cancer Network, Novartis Oncology, Oncology Nursing Society, and Pfizer Inc. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
588 ▼a Description based on online resource; title from PDF title page (viewed August 26, 2017).
590 ▼a Added to collection customer.56279.3 - Master record variable field(s) change: 072
65012 ▼a Lung Neoplasms ▼x diagnosis. ▼0 https://id.nlm.nih.gov/mesh/D008175Q000175
65012 ▼a Lung Neoplasms ▼x epidemiology. ▼0 https://id.nlm.nih.gov/mesh/D008175Q000453
65022 ▼a Mass Screening. ▼0 https://id.nlm.nih.gov/mesh/D008403
650 0 ▼a Lungs ▼x Cancer ▼x Treatment ▼v Congresses.
650 7 ▼a Lungs ▼x Cancer ▼x Treatment. ▼2 fast ▼0 (OCoLC)fst01003773
650 7 ▼a HEALTH & FITNESS / Diseases / General ▼2 bisacsh
650 7 ▼a MEDICAL / Clinical Medicine ▼2 bisacsh
650 7 ▼a MEDICAL / Diseases ▼2 bisacsh
650 7 ▼a MEDICAL / Evidence-Based Medicine ▼2 bisacsh
650 7 ▼a MEDICAL / Internal Medicine ▼2 bisacsh
651 2 ▼a United States ▼x epidemiology. ▼0 https://id.nlm.nih.gov/mesh/D014481Q000453
655 7 ▼a Conference papers and proceedings. ▼2 fast ▼0 (OCoLC)fst01423772
655 4 ▼a Electronic books.
7001 ▼a Patlak, Margie, ▼e rapporteur.
7001 ▼a Nass, Sharyl J., ▼e rapporteur.
7102 ▼a National Cancer Policy Forum (U.S.), ▼e sponsoring body.
7112 ▼a Implementation of Lung Cancer Screening (Workshop) ▼d (2016 : ▼c Washington, D.C.)
77608 ▼i Print version: ▼t Implementation of lung cancer screening. ▼d National Academies Press, 2017 ▼z 9780309451321 ▼w (OCoLC)964380957
830 0 ▼a Online access: National Academy of Sciences National Academies Press.
85640 ▼3 EBSCOhost ▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1546474
938 ▼a YBP Library Services ▼b YANK ▼n 14668838
938 ▼a EBL - Ebook Library ▼b EBLB ▼n EBL4895145
938 ▼a EBSCOhost ▼b EBSC ▼n 1546474
990 ▼a 관리자
994 ▼a 92 ▼b N$T